LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

MORGAN STANLEY's Holding History (CIK: 0000895421)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 866,403 Value ($000) $466 Avg Close — Range —
Q4 2024
Shares 1,214,287 Value ($000) $777 Avg Close — Range —
Q3 2024
Shares 1,727,908 Value ($000) $2,385 Avg Close — Range —
Q2 2024
Shares 450,760 Value ($000) $654 Avg Close — Range —
Q1 2024
Shares 545,367 Value ($000) $1,216 Avg Close — Range —
Q4 2023
Shares 547,597 Value ($000) $1,062 Avg Close — Range —
Q3 2023
Shares 254,940 Value ($000) $375 Avg Close — Range —
Q2 2023
Shares 351,515 Value ($000) $1,118 Avg Close — Range —
Q1 2023
Shares 245,674 Value ($000) $580 Avg Close — Range —
Q4 2022
Shares 218,888 Value ($000) $760 Avg Close — Range —
Q3 2022
Shares 415,089 Value ($000) $3,042 Avg Close — Range —
Q2 2022
Shares 216,894 Value ($000) $1,415 Avg Close — Range —
Q1 2022
Shares 358,040 Value ($000) $1,808 Avg Close — Range —
Q4 2021
Shares 1,001,744 Value ($000) $7,754 Avg Close — Range —
Q3 2021
Shares 539,001 Value ($000) $7,978 Avg Close — Range —
Q2 2021
Shares 1,646,846 Value ($000) $26,745 Avg Close — Range —